• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖皮质激素诱导性骨质疏松症——间充质基质细胞紊乱?

Glucocorticoid-induced osteoporosis - a disorder of mesenchymal stromal cells?

机构信息

Centre for Endocrinology, Diabetes and Metabolism, The Institute of Biomedical Research, The Medical School, University of Birmingham Birmingham, UK.

出版信息

Front Endocrinol (Lausanne). 2011 Aug 27;2:24. doi: 10.3389/fendo.2011.00024. eCollection 2011.

DOI:10.3389/fendo.2011.00024
PMID:22654798
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3356084/
Abstract

Glucocorticoids are a class of steroid hormones that are essential to life but cause serious harm in excess. The main clinical features of glucocorticoid excess are due to adverse effects on cells and tissues that arise from a common developmental precursor - the mesenchymal stromal cell (MSC; sometimes referred to as the mesenchymal stem cell). Interestingly glucocorticoids appear essential for the differentiation of cells and tissues that arise from MSCs. High levels of glucocorticoids are used in tissue engineering strategies to enhance the formation of tissues such as bone, cartilage, and muscle. This article discusses the paradox that glucocorticoids both enhance and impair MSC development and function. It will describe how endogenous glucocorticoids are likely to be important in these processes in vivo and will discuss the implications for therapies aimed at reducing the damage associated with the use of therapeutic glucocorticoids.

摘要

糖皮质激素是一类甾体激素,对生命至关重要,但过量会造成严重损害。糖皮质激素过多的主要临床特征是由于对细胞和组织的不良影响,这些细胞和组织来源于一种共同的发育前体——间充质基质细胞(MSC;有时也称为间充质干细胞)。有趣的是,糖皮质激素似乎对来源于 MSC 的细胞和组织的分化是必需的。高水平的糖皮质激素被用于组织工程策略中,以增强骨、软骨和肌肉等组织的形成。本文讨论了糖皮质激素既能增强又能损害 MSC 发育和功能的矛盾现象。它将描述内源性糖皮质激素在这些体内过程中可能是如何重要的,并讨论针对减少与使用治疗性糖皮质激素相关的损害的治疗方法的意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c73e/3356084/29aa4dca6743/fendo-02-00024-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c73e/3356084/3325ea4af539/fendo-02-00024-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c73e/3356084/29aa4dca6743/fendo-02-00024-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c73e/3356084/3325ea4af539/fendo-02-00024-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c73e/3356084/29aa4dca6743/fendo-02-00024-g002.jpg

相似文献

1
Glucocorticoid-induced osteoporosis - a disorder of mesenchymal stromal cells?糖皮质激素诱导性骨质疏松症——间充质基质细胞紊乱?
Front Endocrinol (Lausanne). 2011 Aug 27;2:24. doi: 10.3389/fendo.2011.00024. eCollection 2011.
2
The shift in the balance between osteoblastogenesis and adipogenesis of mesenchymal stem cells mediated by glucocorticoid receptor.糖皮质激素受体介导的间充质干细胞成骨细胞生成和脂肪生成之间平衡的转变。
Stem Cell Res Ther. 2019 Dec 5;10(1):377. doi: 10.1186/s13287-019-1498-0.
3
Allogeneic Mesenchymal Stem Cell Therapy Promotes Osteoblastogenesis and Prevents Glucocorticoid-Induced Osteoporosis.同种异体间充质干细胞疗法促进成骨细胞生成并预防糖皮质激素诱导的骨质疏松症。
Stem Cells Transl Med. 2016 Sep;5(9):1238-46. doi: 10.5966/sctm.2015-0347. Epub 2016 Jun 30.
4
Elevated Expression of Dkk-1 by Glucocorticoid Treatment Impairs Bone Regenerative Capacity of Adipose Tissue-Derived Mesenchymal Stem Cells.糖皮质激素治疗导致 Dkk-1 表达升高,损害脂肪组织来源的间充质干细胞的骨再生能力。
Stem Cells Dev. 2018 Jan 15;27(2):85-99. doi: 10.1089/scd.2017.0199.
5
Tetramethylpyrazine Protects Against Glucocorticoid-Induced Apoptosis by Promoting Autophagy in Mesenchymal Stem Cells and Improves Bone Mass in Glucocorticoid-Induced Osteoporosis Rats.川芎嗪通过促进间充质干细胞自噬保护糖皮质激素诱导的细胞凋亡,并改善糖皮质激素诱导的骨质疏松大鼠的骨量。
Stem Cells Dev. 2017 Mar 15;26(6):419-430. doi: 10.1089/scd.2016.0233. Epub 2017 Jan 4.
6
Differential effects of dexamethasone on the chondrogenesis of mesenchymal stromal cells: influence of microenvironment, tissue origin and growth factor.地塞米松对间充质基质细胞软骨生成的影响:微环境、组织来源和生长因子的影响。
Eur Cell Mater. 2011 Nov 24;22:302-19; discussion 319-20. doi: 10.22203/ecm.v022a23.
7
In vitro effects of RU486 on proliferation and differentiation capabilities of human bone marrow mesenchymal stromal cells.RU486 对人骨髓间充质基质细胞增殖和分化能力的体外影响。
Steroids. 2012 Jan;77(1-2):132-7. doi: 10.1016/j.steroids.2011.10.017. Epub 2011 Nov 7.
8
Spontaneous In Vivo Chondrogenesis of Bone Marrow-Derived Mesenchymal Progenitor Cells by Blocking Vascular Endothelial Growth Factor Signaling.通过阻断血管内皮生长因子信号传导实现骨髓间充质祖细胞的体内自发软骨生成
Stem Cells Transl Med. 2016 Dec;5(12):1730-1738. doi: 10.5966/sctm.2015-0321. Epub 2016 Jul 26.
9
Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives.糖皮质激素性骨质疏松症:发病机制、治疗及未来展望。
Lancet Diabetes Endocrinol. 2013 Sep;1(1):59-70. doi: 10.1016/S2213-8587(13)70045-7. Epub 2013 Jun 28.
10
Molecular Actions of Glucocorticoids in Cartilage and Bone During Health, Disease, and Steroid Therapy.糖皮质激素在健康、疾病和类固醇治疗期间对软骨和骨的分子作用。
Physiol Rev. 2016 Apr;96(2):409-47. doi: 10.1152/physrev.00011.2015.

引用本文的文献

1
Tocotrienol as a Protecting Agent against Glucocorticoid-Induced Osteoporosis: A Mini Review of Potential Mechanisms.生育三烯酚作为一种对抗糖皮质激素诱导的骨质疏松症的保护剂:潜在机制的小型综述。
Molecules. 2022 Sep 9;27(18):5862. doi: 10.3390/molecules27185862.
2
Antiosteoporosis Effects, Pharmacokinetics, and Drug Delivery Systems of Icaritin: Advances and Prospects.淫羊藿苷的抗骨质疏松作用、药代动力学及药物递送系统:研究进展与展望
Pharmaceuticals (Basel). 2022 Mar 24;15(4):397. doi: 10.3390/ph15040397.
3
Osteocytes Enhance Osteogenesis by Autophagy-Mediated FGF23 Secretion Under Mechanical Tension.

本文引用的文献

1
Conversion of vascular endothelial cells into multipotent stem-like cells.血管内皮细胞向多能干细胞样细胞的转化。
Nat Med. 2010 Dec;16(12):1400-6. doi: 10.1038/nm.2252. Epub 2010 Nov 21.
2
The 11beta-hydroxysteroid dehydrogenase enzymes--arbiters of the effects of glucocorticoids in synovium and bone.11β-羟类固醇脱氢酶——滑膜和骨中糖皮质激素作用的裁决者。
Rheumatology (Oxford). 2010 Nov;49(11):2016-23. doi: 10.1093/rheumatology/keq212. Epub 2010 Jul 15.
3
Adrenal gland and bone.肾上腺和骨骼。
骨细胞在机械张力下通过自噬介导的成纤维细胞生长因子23分泌增强骨生成。
Front Cell Dev Biol. 2022 Jan 31;9:782736. doi: 10.3389/fcell.2021.782736. eCollection 2021.
4
Limethason reduces airway inflammation in a murine model of ovalbumin-induced chronic asthma without causing side effects.Limethason可减轻卵清蛋白诱导的慢性哮喘小鼠模型的气道炎症,且无副作用。
Exp Ther Med. 2018 Mar;15(3):2269-2276. doi: 10.3892/etm.2018.5691. Epub 2018 Jan 4.
5
Age-related Changes in Bone Marrow Mesenchymal Stromal Cells: A Potential Impact on Osteoporosis and Osteoarthritis Development.骨髓间充质基质细胞的年龄相关性变化:对骨质疏松症和骨关节炎发展的潜在影响。
Cell Transplant. 2017 Sep;26(9):1520-1529. doi: 10.1177/0963689717721201.
6
Dexamethasone in osteogenic medium strongly induces adipocyte differentiation of mouse bone marrow stromal cells and increases osteoblast differentiation.在成骨培养基中的地塞米松强烈诱导小鼠骨髓基质细胞的脂肪细胞分化并增加成骨细胞分化。
BMC Cell Biol. 2015 Mar 13;16:9. doi: 10.1186/s12860-015-0056-6.
7
Disruption of glucocorticoid signaling in chondrocytes delays metaphyseal fracture healing but does not affect normal cartilage and bone development.软骨细胞中糖皮质激素信号的破坏会延迟干骺端骨折愈合,但不影响正常的软骨和骨骼发育。
Bone. 2014 Dec;69:12-22. doi: 10.1016/j.bone.2014.08.016. Epub 2014 Sep 3.
8
Chronic restraint stress decreases the repair potential from mesenchymal stem cells on liver injury by inhibiting TGF-β1 generation.慢性束缚应激通过抑制转化生长因子-β1的产生来降低间充质干细胞对肝损伤的修复潜能。
Cell Death Dis. 2014 Jun 26;5(6):e1308. doi: 10.1038/cddis.2014.257.
9
Aging periosteal progenitor cells have reduced regenerative responsiveness to bone injury and to the anabolic actions of PTH 1-34 treatment.衰老的骨膜祖细胞对骨损伤及甲状旁腺激素1-34(PTH 1-34)治疗的合成代谢作用的再生反应性降低。
Bone. 2014 May;62:79-89. doi: 10.1016/j.bone.2014.02.002. Epub 2014 Feb 12.
Arch Biochem Biophys. 2010 Nov 1;503(1):137-45. doi: 10.1016/j.abb.2010.06.007. Epub 2010 Jun 11.
4
Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor.糖皮质激素通过单体糖皮质激素受体抑制成骨细胞分化来抑制骨形成。
Cell Metab. 2010 Jun 9;11(6):517-31. doi: 10.1016/j.cmet.2010.05.005.
5
Glucocorticoid-induced myopathy.糖皮质激素诱导性肌病。
Joint Bone Spine. 2011 Jan;78(1):41-4. doi: 10.1016/j.jbspin.2010.02.025. Epub 2010 May 14.
6
The 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy.11-β-羟类固醇脱氢酶 1 型抑制剂 INCB13739 可改善二甲双胍单药治疗控制不佳的 2 型糖尿病患者的高血糖。
Diabetes Care. 2010 Jul;33(7):1516-22. doi: 10.2337/dc09-2315. Epub 2010 Apr 22.
7
Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice.内源性糖皮质激素减少老年小鼠的骨骼血管生成、血管密度、水合作用和强度。
Aging Cell. 2010 Apr;9(2):147-61. doi: 10.1111/j.1474-9726.2009.00545.x. Epub 2009 Dec 28.
8
Clinical features associated with glucocorticoid receptor polymorphisms. An overview.与糖皮质激素受体基因多态性相关的临床特征。综述。
Ann N Y Acad Sci. 2009 Oct;1179:179-98. doi: 10.1111/j.1749-6632.2009.05013.x.
9
11Beta-hydroxysteroid dehydrogenase type 1 and its role in the hypothalamus-pituitary-adrenal axis, metabolic syndrome, and inflammation.11β-羟类固醇脱氢酶 1 及其在下丘脑-垂体-肾上腺轴、代谢综合征和炎症中的作用。
J Clin Endocrinol Metab. 2009 Dec;94(12):4645-54. doi: 10.1210/jc.2009-1412. Epub 2009 Oct 16.
10
Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice.在病理生理条件下,内源性糖皮质激素和胰岛素信号受损均会刺激小鼠的肌肉消耗。
J Clin Invest. 2009 Oct;119(10):3059-69. doi: 10.1172/JCI38770. Epub 2009 Sep 14.